Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

BSX

+ Watchlist+ Portfolio

Boston Scientific Corp.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Previous Close
$52.01
52-Week Range
$42.20 – $109.50
Market Cap
$71.55B
P/E (TTM)
19.99
EPS (TTM)
2.47
Dividend Yield
Advanced Metrics
Price/Book
2.87
PEG Ratio
0.75
Return on Equity
15.34%
Return on Assets
6.19%
Gross Margin
69.19%
Operating Margin
22.90%
Profit Margin
17.50%
Current Ratio
1.24
Debt/Equity
0.50
Total Debt
$12.62B
Free Cash Flow
$2.45B
Revenue Growth
7.50%
Earnings Growth
15.10%
Enterprise Value
$87.70B

Market Snapshot

About

Boston Scientific Corporation is a global medical device company developing, manufacturing, and marketing medical devices used in interventional medical specialties including cardiology, peripheral interventions, electrophysiology, neurology, women's health, and gastroenterology. The company's product portfolio includes drug-eluting stents, cardiac rhythm management devices (pacemakers, defibrillators), ablation catheters, endoscopy devices, surgical instruments, and urological products. Boston Scientific serves physicians, hospitals, ambulatory surgery centers, and patients globally through direct sales and distributors. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific has grown through internal innovation and strategic acquisitions including Guidant's cardiac rhythm management business and numerous tuck-in acquisitions. The company operates manufacturing facilities worldwide and conducts extensive research and development. Boston Scientific benefits from aging populations, increasing cardiovascular and neurological disease prevalence, and minimally invasive procedure adoption. The company has successfully rebuilt its product pipeline and returned to consistent growth after earlier challenges. Boston Scientific continues to invest in innovation, clinical evidence development, and geographic expansion, particularly in emerging markets.